https://www.orthoworld.com
ORTHOWORLD
Anika Therapeutics Reports 1Q18 Orthobiologic Revenue
Anika Therapeutics posted 1Q18 orthobiologic revenue of US $19.5MM, -3.6% vs. 1Q17.
Empowering Orthopaedic Executives through Strategic Intelligence
Product Labels: Viscosupplement
Tags: Revenue Report